SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is trending as community members highlight bullish price action and speculate about future growth potential. Conversations mention the potential for significant gains and the coin's strong community support. Some users are drawing comparisons to other meme coins on Solana, suggesting a broader interest in the sector.

TOSHI

TOSHI.X is trending as the community rallies around the meme coin, anticipating significant gains and a potential Binance listing soon. Bullish sentiment is fueled by recent listings, the coin's association with Coinbase, and its status as the 'face of base'. Traders are closely watching for a breakout, with some suggesting a coordinated buy to propel the price higher.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending as the community rallies around the Solana-based meme token and its unique branding, highlighted by the playful "What's UpDog?" catchphrase. Community members are actively celebrating $UPDOG.X's presence on the Jupiter Strict List and its resilient, long-term development within the memecoin sector.

Nyvo is a cutting-edge platform that allows anyone to create fully functional decentralized applications (dApps) using simple natural language prompts. In other words, users describe the app they want in plain English, and Nyvo’s AI-driven engine automatically generates both the on-chain smart contract backend and the web-based frontend, delivering a live blockchain application within minutes. This “prompt-to-dApp” approach dramatically lowers the barriers to Web3 development by removing the need to write code or navigate complex developer tools.The result is that developers, entrepreneurs, and even non-technical users can go from an idea to a deployed dApp faster and easier than ever before.

Nyvo

Nyvo ($NYVO.X) is trending as social media buzz points to strong chart momentum and a potential breakout. The crypto community is signaling a 'buy now' opportunity, anticipating a rapid price increase. Conversations evoke a sense of urgency, suggesting a 'rocket' is about to launch.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community anticipates upcoming revenue figures and discusses treasury mechanics.  Enthusiasm is building around its real-world asset (RWA) adoption and potential for significant growth. Some users are also discussing potential integrations with other tokens.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending due to the formation of its board and after-hours trading activity. However, some investors are concerned about a dilutive deal involving warrants without a lock-up period. The community is actively discussing the potential impact of these factors on the stock's price.

Featured in Matt Furies latest book Cortex Vortex as Ratos nemesis. The character is also part of ZOGZ which confirms its real name.  Matt Furie, the artist best known for creating Pepe the Frog, has been working on a new book. The news comes from his editor, who goes by the handle @beuys_on_sale_ on Instagram. In a recent post, the editor hinted at an upcoming project featuring new characters named Gasspas and Rato. Gasspas’s visual appearance can be inferred from the artwork. In one illustration, Gasspas is depicted looming over two rats (Rato and Wat), gazing down at them in a menacing way (an image that has circulated among collectors). This inferred that Gasspas is Ratos nemesis in the new book Cortex Vortex reinforced by community quips that “cats eat rats”. Gasspas debuted as part of ZOGZ, a collection of 111 original NFT character illustrations by Matt Furie launched in May 2023.

Gasspas

$GASS.X is trending as community members highlight its potential, drawing comparisons to $PEPE.X due to its connection with creator Matt Furie, and some are pointing to a recent listing. Community members are actively discussing holding for long-term gains, emphasizing accumulation during dips, and expressing excitement about the project's future.

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Cullinan Therapeutics Inc

Cullinan Oncology Inc

Cullinan Oncology is trending due to analyst upgrades and upcoming presentations at the ASCO and other medical conferences, highlighting data related to their cancer treatment pipeline. Community members are actively discussing the company's valuation, pipeline potential, and recent insider trading activity. A recent analysis comparing CGEM to a competitor, BDTX, is also circulating.

Mamo turns what used to be complex into easy, human-first routines.  It works quietly in the background, finding smart opportunities for your money while you focus on what matters in your life. Think of Mamo as your knowledgeable friend who understands how to help your money grow and explain everything in plain language.  Behind the scenes, Mamo applies proven strategies and real-time data to optimize your portfolio, reinvest earnings when conditions are right, and adapt to market shifts — all with your approval and full transparency.  No noise. No confusion. Just calm, steady growth.

Mamo

MAMO.X is trending as the community discusses its potential integration with the Base App and speculation around a Coinbase listing, which could expose it to millions of new users. Some users are drawing comparisons to other Base ecosystem tokens like AERO.X, while others are focused on its AI-driven utility and staking rewards.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI.X is trending as the tokenization of the identity of the crypto industry. The community is rallying around the narrative that "We are all Satoshi", viewing the token as a legacy play with potential for significant growth. As a meme version of Bitcoin, it's considered a second chance to get in early on a foundational crypto concept.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TNDM Stock Falls on Q2 Earnings Miss, Revenues Beat, Gross Margin Up

Tandem Diabetes posts record Q2 sales and higher margins, but earnings miss sends shares tumbling 20%.

Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Tandem Diabetes Care (TNDM) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates

Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -20.00% and +0.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It?

ABT's Diabetes Care sales surge 19.6% in Q2, fueled by strong U.S. demand and new OTC approvals for its CGM systems.

Bears are Losing Control Over Tandem Diabetes Care (TNDM), Here's Why It's a 'Buy' Now

Tandem Diabetes Care (TNDM) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of -87.50% and +3.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know

Stereotaxis (STXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: Should You Buy?

Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Down 27.0% in 4 Weeks, Here's Why You Should You Buy the Dip in Tandem Diabetes Care (TNDM)

The heavy selling pressure might have exhausted for Tandem Diabetes Care (TNDM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Citi adjusts MedTech outlook: Bullish on Haemonetics, bearish on Tandem Diabetes

Investing.com -- Citi analysts have taken action on two U.S. MedTech names, upgrading Haemonetics (NYSE:HAE) to Buy from Neutral, while downgrading Tandem Diabetes Care (NASDAQ:TNDM) to Sell/High Risk from Neutral/High Risk, citing diverging prospects in the second half of 2025.

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Tandem Diabetes Care Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.33	--	--	N/A
Q2 '25	-$0.40	-$0.48	-20.94%	MISSED
Q1 '25	-$0.60	-$0.67	-10.67%	MISSED
Q4 '24	-$0.21	$0.01	104.72%	BEAT
Q3 '24	-$0.41	-$0.35	14.06%	BEAT

TNDM
Tandem Diabetes Care Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest TNDM News

TNDM Tandem Diabetes Care Inc